Related Experiment Video
Updated: Jul 16, 2026

04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Carotid stent trials: past, present, and future.
1Division of Surgery, Cleveland Clinic, Cleveland, Ohio 44195, USA. ourielk@ccf.org
Perspectives in Vascular Surgery and Endovascular Therapy
|March 14, 2007
Summary
Carotid stenting offers a safe and effective alternative to traditional surgery for high-risk patients with carotid bifurcation disease. Further research is needed to determine its suitability for lower-risk individuals.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Background:
- Carotid endarterectomy is the standard surgical treatment for carotid artery disease.
- Carotid bifurcation disease poses a significant risk of stroke.
- Percutaneous interventions are increasingly explored as alternatives to open surgery.
Purpose of the Study:
- To evaluate the safety and efficacy of carotid stenting as a therapeutic option.
- To compare carotid stenting with carotid endarterectomy for carotid bifurcation disease.
- To assess the role of technological advancements in carotid stenting.
Main Methods:
- Review of contemporary data on carotid stenting procedures.
- Analysis of patient outcomes, focusing on safety and efficacy.
- Consideration of technological improvements in devices and techniques.
Main Results:
- Carotid stenting demonstrates established safety and efficacy for high-grade lesions in high-risk patients.
- Technological advancements have improved the reliability of carotid stenting.
- Ongoing clinical trials are investigating outcomes in lower-risk patient populations.
Conclusions:
- Carotid stenting is a viable alternative to carotid endarterectomy for select high-risk patients.
- Further evidence from clinical trials is required to guide treatment decisions for lower-risk patients.
- The percutaneous approach has the potential to significantly impact global carotid revascularization procedures.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...